$AI

Lath Hitesh sold $200K of AI

Lath Hitesh (CHIEF FINANCIAL OFFICER) sold 20,000 shares of C3.ai, Inc. (AI) at $10.00 ($0.20M total) on 2026-08-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lath Hitesh
Published Aug 6, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 7:44 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AI
Neutral
high confidence
Mentioned
$AI
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AINeutralLow
01

Why it matters

The disclosed open-market sale may slightly influence short-term sentiment, but the pre-arranged 10b5-1 structure reduces interpretability as a new negative signal.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no new operational or financial guidance in the text.

03

What to watch

The article provides only the sale mechanics and post-transaction holdings, with no context on total compensation, other concurrent sales, or any company performance changes.

Relevance 3/10Novelty 3/10Timing: Filed 2026-08-06, describing a sale executed 2026-08-04.

Background

This is an SEC Form 4 insider transaction disclosure for C3.ai, Inc., reported by the CFO.

Company-level read

Ticker impact

$AINeutralHigh confidence
Context

C3.ai CFO Lath Hitesh filed a Form 4 open-market sale of 20,000 shares at $10.00 on 2026-08-04 under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely limited unless accompanied by other company-specific news.

Evidence & confidence

Form 4 details a scheduled sale (10b5-1) with no accompanying guidance, contract, or operational update in the text.

Market effects

Minimal; insider-sale filings rarely reset sector expectations without additional company disclosures.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect diversification or liquidity needs rather than bearish expectations.

Key entities

  • C3.ai, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Lath Hitesh

    Chief Financial Officer who sold 20,000 shares.

Related articles

$AIMed

Trump Family Pockets Half A Billion As Trump-Backed Crypto Firm Moves To Sell Only Revenue-Generating Business

The Wall Street Journal reports Nasdaq-listed AI Financial (formerly Alt5 Sigma) is in talks to sell its only revenue-generating payments subsidiary to Tokyo-based Perpetuals.com for up to $15 million. The unit generated about $25 million revenue in 2024. AI Financial’s losses followed World Liberty’s August 2025 WLFI token purchase and WLFI’s ~70% decline, with AI Financial reporting a $271 million quarterly loss.

$AIMedAI 9/10

C3.ai Q4 2026 Earnings Call Transcript - C3.ai (NYSE:AI)

C3.ai held its Q4 earnings call, reporting total revenue of $51.6 million, with subscription revenue 94% of the total. The company said it cut headcount about 35% and expects ~$135 million in annual operating cost savings. CEO Tom Siebel cited poor sales execution and plans to expand its target accounts. FY2027 guidance calls for $210–$240 million revenue and non-GAAP operating loss of $128–$160 million.

$AIHighAI 9/10

Live: Will C3.ai Beat Q4 Earnings After the Bell Tonight?

C3.ai (AI) reports Q4 fiscal 2026 results after the close. The company is focused on revenue within guidance ($48.0M–$52.0M), improving GAAP gross margin from 17% (down from 59% a year earlier), and expanding federal bookings, which rose 134% YoY to 55% of total bookings. Wall Street has 6 sell and 7 hold ratings; average target is $8.82 vs. $10.51.

$AIMedAI 8/10

Wall Street Has a Consensus on This AI Stock. The Consensus Is Dead Wrong.

The article argues that Wall Street’s consensus on C3.ai (AI) is inconsistent and may not reflect deteriorating fundamentals. It cites a hold consensus from 12 analysts with an average price target near $17 versus a stock price around $9.50. For fiscal Q1 2026 ended July 31, C3.ai reported about $50M revenue, missed guidance, posted a $0.40 loss per share vs $0.30 estimate, and guided continued pressure.

$AIMedAI 9/10

Thomas Siebel Is Back as C3.ai CEO. Will This Help the Stock Rebound?

C3.ai shares are down 59% over 12 months as the company’s sales have declined, despite having 100+ enterprise AI turnkey solutions. After CEO/founder Thomas Siebel stepped down in 2024 for health reasons and Stephen Ehikian took over Sept. 1, 2025, C3.ai reported preliminary Q4 revenue of $51.6M vs. $108.7M a year earlier. The company says Siebel returned as CEO May 8.